New hope for rare brain fungus: experimental drug olorofim enters trial
Disease control
Not yet recruiting
This study tests an experimental drug called olorofim in people recently diagnosed with coccidioidal meningitis, a rare fungal infection of the brain and spinal cord. About 12 adults will take the drug for 6 months to see if it is safe and helps control the infection. The goal is…
Phase: PHASE2 • Sponsor: Fariba Donovan • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC